Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Study

Evaluation of the quality of 'do not use' medication abbreviation audits: a key enabler to successful implementation of audit and feedback.

Li E, Marrandino J, Marshall S, et al. Evaluation of the quality of ‘do not use’ medication abbreviation audits: a key enabler to successful implementation of audit and feedback. Int J Clin Pharm. 2021;43(3):748-752. doi:10.1007/s11096-021-01232-3.

Save
Print
March 24, 2021
Li E, Marrandino J, Marshall S, et al. Int J Clin Pharm. 2021;43(3):748-752.
View more articles from the same authors.

National organizations have undertaken efforts to eliminate the use of error-prone abbreviations to reduce medication errors. This study found that pharmacy staff audits may under-report use of these “do not use” abbreviations, which may limit the effectiveness of audit systems and place patients at risk for harm. 

Save
Print
Cite
Citation

Li E, Marrandino J, Marshall S, et al. Evaluation of the quality of ‘do not use’ medication abbreviation audits: a key enabler to successful implementation of audit and feedback. Int J Clin Pharm. 2021;43(3):748-752. doi:10.1007/s11096-021-01232-3.

Related Resources From the Same Author(s)